Stock research
MIRM Mirum Pharmaceuticals, Inc.
Healthcare • Biotechnology
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral...…
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
ALL change
+560.91%
Range high
$128.57
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in MIRM?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $105.79
- Day High
- $96.99
- Day Low
- $88.88
- 52w High
- $130.00
- 52w Low
- $54.75
- Volume
- 1,326,700
- Avg Volume
- Beta
- 0.485
* TTM/most recent where available
Company
- Ticker
- MIRM
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Christopher Peetz
- Employees
- 372
- Website
- www.mirumpharma.com
Key Metrics
- Market Cap
- 5.72B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).